Skip to main content
Premium Trial:

Request an Annual Quote

Steven Verdooner, Richard Lai Fatt

Premium
eXegenics said this week that it has named Steven Verdooner as its executive vice president of instrumentation.
 
Verdooner previously held various managerial positions at Ophthalmic Imaging Systems, an ophthalmic digital imaging and informatics firm he co-founded.
 
eXegenics announced the hiring of Verdooner when it reported an agreement to buy ophthalmic imaging and diagnostics company Ophthalmic Technologies.
 

 
Nventa Biopharmaceuticals said this week that it has appointed Richard Lai Fatt as its vice president of corporate development.
 
Lai Fatt previously was vice president of business development and strategic marketing at antisense firm Isis Pharmaceuticals.
 

 
Biogen Idec said this week that it has appointed Marijn Dekkers to its board of directors.
 
Dekkers is president and CEO of Thermo Fisher Scientific.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.